GLP-1 Weight Loss Online in 2026: Costs, Providers, Safety

GLP-1 weight loss online means a licensed clinician prescribes semaglutide or tirzepatide after a web-based intake, and a pharmacy mails the medication to your home. The product is either an FDA-approved brand (Wegovy, Zepbound, the Wegovy pill, Foundayo) or a compounded version made by a state-licensed pharmacy, and compounded cash prices start at $49 a month.

Not long ago, the same prescription meant a specialist appointment, a battle with your insurer and a pharmacy that might be out of stock. Today an online questionnaire can lead to a cold-packed delivery at your door, sometimes for less than a typical copay. That ease built a whole industry, and with it plenty of confusion about what is actually being sold.

This is the full-length reference for anyone deciding whether a GLP-1 makes sense before they spend a dollar. It covers how the drugs work, how to pick between the two molecules, what is legal, who qualifies, what every verified provider charges, how the process runs from intake to first dose, how to judge a provider, what the first twelve weeks are like, what the trials really found, and where people get caught out. Each section works on its own, so jump to the one you need. Shorter guides linked along the way go deeper on single questions.

Which three routes lead to a legal GLP-1 prescription online?

Route 1: brand-name medication through a telehealth prescriber. Wegovy (semaglutide) and Zepbound (tirzepatide) are the FDA-approved weekly injections for chronic weight management. Two daily tablets are now approved as well: the Wegovy pill (oral semaglutide 25 mg) and Foundayo (orforglipron). A telehealth company such as ro can prescribe them, bill your insurer where coverage applies, or sell them for cash. Only on this route has the finished product itself gone through FDA review.

Route 2: compounded semaglutide or tirzepatide through a telehealth program. A state-licensed compounding pharmacy makes the same active ingredient for you on a clinician's patient-specific prescription. The result is not an FDA-approved product, and that trade-off is why prices begin at $49 a month rather than in the thousands. Most providers we cover use this model, including embody, welludr, altRx, Eden, Medvi, TrimRx and DirectMeds.

Route 3: brand-name medication billed to your own insurance. When your plan covers Wegovy or Zepbound for weight loss, a telehealth prescriber can handle the prior authorization and send the prescription to a retail or mail-order pharmacy like any other. Coverage attaches to the drug, not to whether you met the clinician in person or online. The GLP-1 insurance guide lists what plans usually ask for.

The common thread: a licensed clinician reads your health history and decides whether to prescribe. No legal path skips that step. A site that sells a GLP-1 without it is offering something you should not inject.

How should you read the prices quoted here?

We read every provider price in this guide on that provider's own website on October 16, 2026, and each one is shown with its condition attached, such as a 12-month plan, a first-month promotion or a flat rate at every dose. Prices move. The provider's page is always the live source, and our GLP-1 price-change log records each change we have caught since tracking began. Figures from manufacturers or third parties carry their date and are marked as not verified by us. When we could not confirm something, we say so instead of guessing.

GLP-1 medications copy a gut hormone, glucagon-like peptide-1, that tells the brain you have eaten, slows how fast the stomach empties and prompts insulin release. Engineered to last for days instead of minutes, a once-weekly dose keeps that fullness signal running, and in the pivotal trials it produced average weight loss of 14.9% (semaglutide) to 20.9% (tirzepatide, top dose).

Your body makes GLP-1 within minutes of a meal, and the natural hormone is broken down within a couple of minutes. The drug versions resist that breakdown. What most people notice first is not a surge of willpower but quieter hunger: smaller meals feel like enough, and the constant mental chatter about food fades. Our explainer on how GLP-1 medications work covers the physiology in plain English.

How is tirzepatide different from semaglutide?

Semaglutide activates one receptor, GLP-1. Tirzepatide activates two, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), which is why it gets called a "dual agonist" and part of why it delivered more average weight loss in its trials. Both are weekly injections under the skin, and both begin at a low dose that is raised over several months to keep stomach side effects manageable.

What weight loss did STEP 1 and SURMOUNT-1 show?

Almost every credible claim about these drugs leads back to two studies. Both were randomized, double-blind and placebo-controlled, enrolled adults with obesity (or overweight plus a weight-related condition) who did not have diabetes, and added the drug to lifestyle advice.

Sources: Wilding et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, March 18, 2021; Jastreboff et al., Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine, July 21, 2022. The SURMOUNT-1 numbers in the table use the treatment-regimen estimand. The paper's efficacy estimand, which assumes every participant stayed on the drug, reaches 22.5% at 15 mg, and that larger figure is the one most ads repeat.

Keep three limits in mind when reading those numbers:

• They are averages. In STEP 1 roughly a third of participants lost 20% or more while some lost very little, and no intake form can tell you in advance which group you will land in.
• They were measured at full maintenance dose after a long titration. They describe month fifteen, not month two.
• Everyone in the trials got lifestyle counseling. That is more support than most telehealth programs include.

Read the trial results as a ceiling that a well-managed, fully dosed course can approach, not as a promise attached to a $49 plan.

What happens to the weight when you stop a GLP-1?

Weight comes back for most people, and this is the result that should shape your budget. In the STEP 1 extension, people who stopped both semaglutide and the lifestyle program regained about two-thirds of the weight they had lost within one year (Wilding et al., Diabetes, Obesity and Metabolism, published April 19, 2022). Think of these drugs the way you think of blood-pressure medication: they work while you take them. Our guide to what happens when you stop GLP-1 medication covers the tapering and maintenance approaches clinicians use.

Why do the new GLP-1 pills matter?

Until late 2025, a GLP-1 for weight loss always meant a needle. The FDA approved the Wegovy pill (oral semaglutide 25 mg) in December 2025 as the first oral GLP-1 for chronic weight management, and Eli Lilly's Foundayo (orforglipron) followed on April 1, 2026. Both are brand-name, prescription-only and priced like brands, but they take away the injection, which kept many people from starting at all.

The daily routines differ. The Wegovy pill must be swallowed on an empty stomach with a sip of water, followed by a 30-minute wait before food. Foundayo has no food or water rules. Our Foundayo vs Wegovy pill comparison lines up their trial results and prices, and GLP-1 pills vs injections explains why the compounded "pills" and "drops" some programs sell belong to a completely different category.

Choose semaglutide if cost, a longer safety record or a pill option matters most; choose tirzepatide if you want the larger average result and can pay more. At the same provider, tirzepatide typically costs roughly $40 to $110 more per month, and in its own trial it produced up to 20.9% average loss against semaglutide's 14.9%.

The molecule is the first real decision, because it shifts both your monthly price and what the evidence says to expect. Neither is right for everyone. Here is how they compare on the factors that usually decide it.

When is semaglutide the better first choice?

• Cost. It is the cheaper molecule at the providers we track, a difference worth $480 to $1,320 across a year.
• Track record. It has more years of real-world use behind it.
• Results that are still large. About 15% average loss is big by any historical yardstick: 33 pounds for someone starting at 220.
• A pill exists. If needles are the barrier, the Wegovy pill is an option.

For a first course, when you do not yet know how your body will react, the order most clinicians describe is to start on the lower-cost molecule and move only if you plateau.

When is tirzepatide worth the higher price?

The trial difference is genuine. At its top dose, tirzepatide's average loss ran about six percentage points ahead of semaglutide's result in its own trial, and a substantially larger share of participants reached 20% or more. Tirzepatide makes sense if your goal is large (60 pounds or more, for example), if you already stalled on semaglutide, or if a clinician thinks the dual mechanism fits your metabolic profile. In those cases the extra spend buys a measurably bigger expected result. See tirzepatide vs semaglutide for the head-to-head evidence and best tirzepatide online for every verified tirzepatide price.

Do semaglutide and tirzepatide have the same side effects?

Mostly, with one notable difference. Both labels list the same leading adverse events (nausea, diarrhea, vomiting, constipation, abdominal pain, reduced appetite), and these bunch up around dose increases. Both carry the same boxed warning about thyroid C-cell tumors seen in rodents, and both are contraindicated with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. The tirzepatide label adds that it can make oral contraceptives less effective for four weeks after starting and after each dose increase. Nobody can reliably predict which molecule you will tolerate better; if one keeps causing side effects, a clinician can slow the titration or switch you. MedlinePlus summarizes the labels for semaglutide and tirzepatide.

So which one is better?

Tirzepatide led to more weight loss in trials. Semaglutide is cheaper, has been around longer and is available as a pill. The better pick depends on how big your goal is, what you can afford over a full year rather than a single month, and how your body responds, which no one can know ahead of time. What is certain: either drug, taken as prescribed at a maintenance dose for a year, produced controlled-trial results that no earlier weight-loss medication came close to.

Compounded semaglutide and tirzepatide are legal when a state-licensed pharmacy prepares them for an individual patient on a clinician's prescription, but they are not FDA-approved. Brand-name Wegovy, Zepbound, the Wegovy pill and Foundayo are FDA-approved and cost far more. Compounded "pills" and "drops" are a third category with no trial data of their own.

Read this section carefully, because it is where most of the money and most of the risk live. "GLP-1 online" covers four different kinds of product that are marketed in similar language but stand on very different legal ground.

Brand-name pens and pills: FDA-approved and priced like it

The FDA approved Wegovy for chronic weight management on June 4, 2021 (FDA press announcement) and Zepbound on November 8, 2023 (FDA press announcement). Every pen is factory-sealed, its contents match what was tested in the trials, and its manufacturing is FDA-inspected. The Wegovy pill and Foundayo have the same standing.

Online cash prices reflect that status. Verified figures at the providers we track:

• Zepbound: $1,249 a month at altRx, $1,599 at welludr.
• Ozempic: $1,399 a month at welludr.
• ro: Zepbound KwikPens from $299 the first month, then $399-$449; the Wegovy pill at $149 the first month, then $299. Both are in addition to the ro membership.

The Zepbound price guide and Wegovy pill price guide keep these numbers current and explain the manufacturers' direct-pay programs, whose prices we cite from dated third-party sources without having verified them ourselves.

Compounded semaglutide and tirzepatide: legal with conditions, never FDA-approved

Compounding means a licensed pharmacist prepares a medication for one patient under a prescription. Federal law permits it under two frameworks, both outlined on the FDA's human drug compounding page:

• Section 503A applies to state-licensed pharmacies compounding for a named patient on an individual prescription. Nearly every telehealth GLP-1 program uses this route, which is why provider sites mention "503A pharmacy" so often.
• Section 503B applies to registered outsourcing facilities that may make larger batches under stricter federal oversight.

Compounded GLP-1s boomed in 2023 and 2024 because semaglutide and tirzepatide both sat on the FDA's drug shortage list, and the law relaxes compounding limits for drugs in shortage. That window is shut. The FDA declared the tirzepatide shortage over on December 19, 2024 and the semaglutide shortage over on February 21, 2025, and the enforcement grace periods ran out in spring 2025 (FDA statement on compounder policies).

What is still allowed is what always was: a 503A pharmacy compounding for one patient when the prescriber records a clinical need the approved product does not meet, such as a different dose, a different formulation, an added ingredient or intolerance to an excipient. Mass-producing copies of the approved drug is not allowed. Enforcement continues and the rules keep shifting. For you, the practical takeaway is that the prescription should be written for you specifically and the pharmacy should be named.

The FDA's own risk summary deserves a full read: FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. In brief, the agency notes that:

• Compounded products are not reviewed for safety, effectiveness or quality before sale.
• It has received adverse-event reports, including dosing errors from vials that require patients to measure their own dose.
• Some products contained salt forms of semaglutide (semaglutide sodium, semaglutide acetate), which are not the active ingredient in the approved drugs.
• Products sold without a prescription or from unlicensed sources may be counterfeit.

None of this makes compounded GLP-1 a scam. It means quality depends on the pharmacy rather than a brand, and you are relying on the telehealth provider's choice of pharmacy. The providers we cover name theirs, and that is the first thing we check. For more depth, see compounded vs brand-name semaglutide and the 503A vs 503B explainer, which also covers the "28-day rule" on beyond-use dating that limits how much a pharmacy can ship at once.

Are compounded GLP-1 "pills," "drops" and "gum" the same as the Wegovy pill?

No. Some programs sell compounded oral semaglutide as tablets, under-the-tongue drops or troches. The FDA-approved Wegovy pill is a specific formulation engineered to survive the stomach. Compounded oral versions have no trials of their own, and a peptide taken by mouth is poorly absorbed without that formulation work. If you want a pill, two approved ones exist. If a program's "pill" is compounded, you are buying an unstudied product, not a discount Wegovy pill. Our weight-loss pills guide sorts out the categories.

What is the quickest way to spot an illegitimate GLP-1 product?

Two tests catch most problems. First, a compounded product described as "FDA-approved" is being described falsely; the FDA made exactly that point in a June 2026 warning letter to altRx's parent company over marketing that implied approval, as our altRx review notes. Second, a product sold without a prescription is not a legal GLP-1 in the United States. Everything else comes down to price, pharmacy and terms, which the rest of this guide covers.

Adults generally qualify with a BMI of 30 or higher, or 27 or higher plus at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol or sleep apnea. A licensed clinician reviews your online intake and can say no, most often because of a thyroid cancer history, pancreatitis, pregnancy or certain medications.

The intake is a real medical review, not paperwork. Depending on the provider and your state, a physician, nurse practitioner or physician assistant reads it and may decline. Knowing the criteria up front can save you a rejection and, at providers that do not refund declined applicants, the fee.

What BMI do you need for Wegovy or Zepbound?

Both labels cover adults with a body mass index of 30 or more, or 27 or more with at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol or obstructive sleep apnea, for example). Telehealth programs prescribing compounded versions usually use the same cut-offs. BMI is weight in kilograms divided by height in meters squared. For someone 5'6" tall, BMI 27 is roughly 167 pounds and BMI 30 roughly 186 pounds. Our GLP-1 eligibility guide includes a full height-by-height table.

What rules you out?

Every provider screens for these:

• Personal or family history of medullary thyroid carcinoma, or of Multiple Endocrine Neoplasia syndrome type 2 (the subject of the boxed warning on both labels).
• Past pancreatitis.
• Severe gastrointestinal disease such as gastroparesis, because the drugs slow stomach emptying.
• Pregnancy, trying to conceive, or breastfeeding. The labels say to stop at least two months before a planned pregnancy.
• Type 1 diabetes, or taking insulin or a sulfonylurea without diabetes supervision, because of the risk of low blood sugar.
• A current or recent eating disorder, at most providers.
• Being under 18, for compounded programs (Wegovy itself is approved from age 12 under specialist care).

Which medications and conditions should you disclose?

Disclose everything. GLP-1s slow stomach emptying, which can change how fast oral medications are absorbed, so the clinician needs your complete list, including thyroid hormone, blood thinners and oral contraceptives. For tirzepatide, the label recommends a backup birth-control method for four weeks after starting and after each dose increase. Kidney disease, diabetic retinopathy, gallbladder disease and a history of depression or suicidal thoughts are not automatic disqualifiers, but you will be asked about them and they may change the plan. Being honest protects you: the answers that could get you declined are the same ones that would make the drug unsafe.

What does the online intake involve?

• Time: about 10 to 25 minutes.
• Questions: height and weight (sometimes with a photo to confirm BMI), medical history, current medications, past weight-loss attempts and goals.
• Consultation: some providers add a short video or phone call.
• Labs: many ask for recent bloodwork and order it if you have none; some accept a written attestation.
• ID: government ID is required because the prescription is in your name.

A clinician then reviews the intake, typically within one to three days (embody usually within 24 hours), and prescribes, asks follow-up questions or declines. If a GLP-1 is not right for you, several providers offer alternatives such as metformin or bupropion-naltrexone, which our Ozempic alternatives guide covers.

What happens to your money if you are declined?

That depends on the provider, so read the refund terms before you apply. embody gives a full refund when a clinician does not approve you. Other providers differ, and some charge a consultation fee that is not refunded. Each provider's review page lists its terms under pricing.

Compounded semaglutide costs $49 to $199 a month online and compounded tirzepatide $89 to $299 a month at the providers we verified on October 16, 2026, while brand-name pens bought for cash start around $1,249 a month. Over a year, compounded semaglutide ranges from $588 (welludr's 12-month plan) to roughly $2,348 (SHED).

People usually search "how much is Ozempic without insurance," but the full answer has three parts: the cash price of the brand-name drug, the price of compounded versions, and the part that catches most people out, which is what you will still be paying in month four at your maintenance dose. Here are all three, using only figures we verified.

What does each provider charge for compounded semaglutide and tirzepatide?

Monthly cash prices as read on each provider's own site on October 16, 2026, with the condition behind the headline number, sorted by semaglutide price. We re-check on a schedule; if this table and a provider's live page ever disagree, the live page wins.

ro does not fit this table because it sells brand-name medication only. Its membership costs $39 the first month and then $74-$149 a month, and the drug is billed on top: the Wegovy pill from $149 and then $299, Wegovy pens from $199, and Zepbound from $299 the first month and then $399-$449. Our cheapest GLP-1 page keeps this table up to date, and the GLP-1 provider comparison adds Trustpilot patterns and refund terms.

Why is the month-four price what really matters?

Four pricing mechanics determine what you pay after the first month, and the headline price conceals every one of them:

• Promotions end. altRx's $89 and Medvi's $99 are promotional prices against a regular $199, and SHED's 20% discount covers month one only. If a $199 plan has a three-month promotion, year one comes to about $2,100, not $1,068.
• Commitment plans lock you in. welludr's $49 and $89 rates require a 12-month plan billed monthly (not prepaid). HealthRx's $99 rate is a 12-month prepaid plan charged as $1,188 at checkout. The savings are real (welludr's committed rate is roughly half a month-to-month equivalent), and so is the cost of quitting early.
• Some prices rise with dose. Some programs outside our table charge more at higher doses. Every provider in the table publishes one price per medication across all doses, which is part of why they made the table. Always confirm on the plan page.
• Fees can be separate. ro bills membership and medication separately, some providers charge an initial consultation, and labs can cost extra. Add up every line item.

What does a full year of compounded semaglutide cost?

Twelve months of medication and program fees at verified rates:

• welludr, 12-month plan: 12 x $49 = $588.
• embody, month to month: 12 x $69 = $828.
• altRx: $1,068 if the promotional rate held all year, $2,388 at the regular rate. Ask altRx about that gap before you start.
• DirectMeds, flat rate: $1,764.
• SHED: roughly $2,348.

Choosing tirzepatide adds between $480 (welludr) and $1,200 (SHED) to those totals. Our breakdown of GLP-1 costs from month one to year one runs the math for every provider, and before you prepay for a GLP-1 is the checklist for commitment plans.

What does brand-name cost with and without insurance?

Paying cash for brand-name through the providers we verify starts at $1,249 a month (Zepbound at altRx) and goes up. ro's pen prices are lower because they sit on top of a membership and often assume insurance. If your commercial plan covers Wegovy or Zepbound, the manufacturers' savings offers are reported to cut the copay sharply, and Medicare's GLP-1 Bridge pilot is reported to charge a flat $50 a month through December 2027. Both figures come from dated third-party sources we have not verified; details are in GLP-1 with insurance and GLP-1 after 65.

Insurance seldom covers compounded medication, so the compounded prices above are cash prices by design. HSA and FSA funds can generally be used, and Medvi and SHED state HSA/FSA eligibility explicitly.

What extra do you get for $100 to $200 a month?

At the bottom of the range you get the medication, a clinician review and shipping, plus portal messaging and dose changes. Higher prices add extras such as:

• Unlimited check-ins (TrimRx).
• A dietitian and coaching included in the price (Medvi).
• A money-back results guarantee (SHED: 5% body-weight loss in 120 days).
• Overnight delivery (HealthRx).
• Brand-name options alongside compounded (altRx, Sprout, welludr).

Those are only worth paying for if you will use them. The medication itself is the same molecule from a licensed pharmacy at $49 or $199. Our guide to what $100 to $200 a month gets you lists it item by item.

Most people go from online intake to first injection in four to ten days at the fastest providers and one to two weeks elsewhere. The steps are the same everywhere: a 15 to 25 minute intake, a clinician review in one to three days, then pharmacy shipping that ranges from overnight to 5-7 days depending on the provider.

Day 0: pick a provider and finish the intake

Plan on fifteen to twenty-five minutes online covering height, weight, a photo, medical history, medications, goals and ID. Some providers charge when you submit and others only on approval. Find out which, because it determines whether a decline costs you anything.

Days 1-3: the clinician review

A licensed clinician reviews your answers, occasionally with a brief video or phone call or a request for labs. embody usually completes its review within 24 hours; most others quote one to three days. The clinician chooses the molecule, starting dose and titration schedule, then sends a patient-specific prescription to the pharmacy. If something in your history needs clarifying you will get a message, and a quick reply keeps things moving.

Days 2-8: the pharmacy fills and ships

The compounding pharmacy prepares your prescription and ships it in an insulated box with ice packs. Verified delivery windows:

• embody and DirectMeds: 1-2 days.
• TrimRx: free tracked delivery, often next day.
• HealthRx: overnight cold-chain.
• Sprout: shipped within 2 days of the prescription.
• welludr: 3-5 business days.
• altRx: 5-7 days.

Late shipments are the most frequent complaint in Trustpilot reviews of every provider, and pharmacy backlogs, not the telehealth company, cause most of them. Our GLP-1 shipping times comparison puts each provider's published promise beside what reviewers report.

Delivery day: inspect what arrived

Put the medication in the fridge as soon as it arrives. The vial or pen should show your name, the drug, the strength, the pharmacy's name and a beyond-use date. If a compounded product shows up unlabeled or without a pharmacy name, stop and contact the provider. Most compounded semaglutide comes as a multi-dose vial with syringes, and you measure the units yourself. That step is where the FDA's dosing-error reports originate, so read the instructions twice and use the provider's video or nurse line for your first dose.

Your first injection

Inject once a week on the same day, under the skin of the belly, thigh or upper arm, rotating spots. The needle is short and thin, and most people say it hurts less than a flu shot. Choose a time when you can eat lightly afterward, since nausea is most likely after the first dose. Keep a short log of date, dose and how you felt; it makes check-ins far more useful.

Week 1 onward: check-ins and dose increases

Your clinician sets up check-ins (messaging at most providers, unlimited at TrimRx, video at Medvi) and raises the dose about every four weeks if you are tolerating it. Refills ship on your plan's schedule; welludr ships every 4 weeks. No provider in our table changes price as the dose goes up. If side effects are more than mild, message before your next dose instead of pushing on; staying at a dose for an extra month is routine. The first-month guide and semaglutide side-effects guide explain what is normal and what is not.

What is a realistic overall timeline?

• Sign-up to first injection: four to ten days at the quick providers, one to two weeks elsewhere.
• First injection to maintenance dose: four to five months.
• First injection to trial-level results: a year or longer.

Any promise of a faster timeline is selling the advertisement, not the medication.

Choose an online GLP-1 provider by checking, in order, that it names a state-licensed pharmacy, uses a licensed US clinician, describes compounded medication honestly, and publishes its maintenance-dose price, commitment and refund terms. Shipping speed, reviews, included services and flexibility come next. These are the twelve checks behind our rankings, and you can run them on any provider.

Our ranking reflects our judgment on our criteria, and your priorities may not match. The full method lives on our how to choose a GLP-1 provider page.

1. Does the provider name its pharmacy, and is that pharmacy state-licensed? A company that will not say who compounds its medication is asking you to trust an anonymous manufacturer. Look for a named 503A pharmacy (or 503B facility) and confirm the license on your state board of pharmacy's website.
2. Does a licensed US clinician review the intake and write a prescription just for you? The provider should state who prescribes (physician, NP or PA) and which states it serves. "Doctor-approved" is a slogan; "a licensed provider in your state reviews your intake" is the standard to look for.
3. Is the medication described truthfully? If "FDA-approved" appears next to a compounded product, leave. If semaglutide is sold as a "pill" or "drops," know that it is compounded and unstudied.
4. What will you pay at your maintenance dose once any promotion ends? Get the regular rate and the promotion length from the plan page, not from an ad.
5. What are you signing up for? Month to month, a 12-month plan billed monthly and a prepaid year carry three very different levels of financial risk. Prepay only once you know you tolerate the drug.
6. What happens if you are declined or want to stop early? Read the refund and cancellation terms. embody's full refund when a clinician does not approve you is the clearest policy we have seen.
7. What does the price include? Check whether clinician visits, messaging, dose changes, shipping, labs and supplies are included or billed separately.
8. How is it shipped, and how quickly? Cold-chain packaging is essential for an injectable peptide. Published delivery windows run from next day to a week, and reviews show whether they are met.
9. What do verified customer reviews praise and complain about? A 4.6 from 2,000 reviews and a 3.8 from 9,000 reviews both tell you something, but recurring themes matter more than the score. Shipping delays and slow support are the two complaints that show up at every provider, and the reviews reveal how each company responds. Our GLP-1 provider support comparison does that reading for you.
10. Is the company accountable? A physical address, a phone number, named leadership, LegitScript certification (embody has it) and a Trustpilot profile with years of history all suggest someone answers for the service.
11. Does the program match the care you want? Some people want a pharmacy and a portal and nothing more; others want a dietitian and weekly calls. Paying for coaching you will not use is the most common way to overspend.
12. Can you make changes without penalty? Switching molecule, pausing for travel or illness and adjusting the dose should all be possible under the plan terms.

What do we leave out of the scoring, and why?

We do not score weight-loss results. A provider cannot make the drug work better; the molecule and dose do that, and responses vary from person to person. A provider advertising its customers' average results is advertising a self-selected group. We also skip "doctor quality," which we cannot verify. What we score is whether a licensed clinician is involved and reachable.

Which provider do we rank first, and when should you pick another?

Our weight-loss provider ranking puts embody first for its combination of the lowest no-commitment price, 1-2 day shipping, LegitScript certification and a full refund if declined. altRx and Eden follow, and welludr is fourth on the strength of the lowest committed price and a 4.6 Trustpilot rating. Reasonable people could order them differently:

• Lowest monthly cost, staying a full year: welludr at $49.
• One month to try it, free to walk away: embody at $69.
• Brand-name and compounded under one roof, flat pricing, Buy Now, Pay Later: altRx.

Our provider matching quiz turns your priorities into a recommendation in about a minute.

We track eleven online GLP-1 providers: embody, welludr, altRx, Eden, Medvi, TrimRx, DirectMeds, SHED, HealthRx, Sprout and ro. Below is each one's verified price as of October 16, 2026, its published shipping and commitment terms, and its Trustpilot rating and review count as captured. Nothing here is estimated.

Every profile links to a full review with pricing captures, pros and cons, verified customer quotes and head-to-head comparisons. The rankings are our opinion; the facts are the providers' own.

embody: how much does it cost and what do you get?

embody charges $69 a month for compounded semaglutide (regular $79) and $119 for tirzepatide (regular $129), month to month with no contract and one price at every dose. Shipping is free, cold-chain and takes 1-2 days. embody is LegitScript-certified, uses 503A pharmacies, usually completes the clinician review within 24 hours and refunds in full if you are not approved. Its Trustpilot rating is 3.8 from 9,604 reviews; reviewers most often complain about shipping delays and most often praise fast support. It is our pick for a first course without commitment. Read the embody review or compare embody vs welludr.

welludr (formerly welludr): how much does it cost and what do you get?

welludr has the lowest ongoing compounded prices we have verified: $49 a month for semaglutide and $89 for tirzepatide on a 12-month plan billed monthly, the same at every dose, shipped every 4 weeks with 3-5 business day delivery. It also lists brand-name Ozempic ($1,399) and Zepbound ($1,599). Trustpilot: 4.6 from 2,188 reviews, with named support staff a frequent positive and shipping delays the main complaint. The company changed its name from welludr to welludr in October 2026 with no change to plans or prices. It ranks fourth on our list. Read the welludr review or compare welludr vs TrimRx.

altRx: how much does it cost and what do you get?

altRx's promotional prices are $89 a month for compounded semaglutide and $149 for tirzepatide (regular $199 and $299), flat at every dose, with no commitment, pause or cancel anytime, Buy Now, Pay Later and free shipping in 5-7 days. It also carries real brand-name stock, including Zepbound at $1,249. We could not verify a Trustpilot aggregate. In June 2026 the FDA sent altRx's parent company a warning letter about marketing that implied its compounded products were FDA-approved; our review explains what changed afterward. Read the altRx review.

Eden: how much does it cost and what do you get?

Eden charges $99 a month for compounded semaglutide and $129 for tirzepatide, one flat price at every dose, with no annual or long-term plan, doctor-guided care and 24/7 human support. Trustpilot: 4.5 from 4,917 reviews. We added Eden to our comparison in October 2026. Read the Eden review.

Medvi: how much does it cost and what do you get?

Medvi's promotional prices are $99 a month for compounded semaglutide and $166 for tirzepatide (regular $199 and $299), and they are all-inclusive: clinician visits, a dietitian and coaching are covered, with no membership or hidden fees, free shipping and HSA/FSA accepted. Trustpilot: 4.3 from 14,987 reviews, the second-largest review base we track. Medvi suits people who want support around the medication, not just the medication. Read the Medvi review.

TrimRx: how much does it cost and what do you get?

TrimRx charges $149 a month for compounded semaglutide with a $140 discount applied, the same at every dose, and $259 for tirzepatide, month to month. Delivery is free, tracked and often next day. Its standout feature is custom dosing with unlimited provider check-ins. Trustpilot: 3.8 from 5,392 reviews. Read the TrimRx review.

DirectMeds: how much does it cost and what do you get?

DirectMeds charges one flat $147 a month for semaglutide or tirzepatide, as injections or drops, at every dose. The telemedicine visit and prescription are included, no insurance or membership is required, and shipping is free in 1-2 days. Trustpilot: 4.6 from 16,390 reviews, the largest review base in our set and tied for the highest rating. The tirzepatide price is the notable part: at $147 flat with no commitment, only embody and Eden charge less for tirzepatide without a plan. Read the DirectMeds review.

SHED: how much does it cost and what do you get?

SHED's compounded semaglutide starts at $199 a month and tirzepatide at $299, with 20% off the first month, coaching included, HSA/FSA approval, home delivery included, and a money-back guarantee if you have not lost 5% of your body weight within 120 days. Trustpilot: 4.6 from 1,134 reviews. That guarantee is what the premium buys. Read the SHED review.

HealthRx: how much does it cost and what do you get?

HealthRx charges $99 a month for compounded semaglutide on a 12-month prepaid plan ($1,188 at checkout) and from $179 a month for tirzepatide, with overnight cold-chain shipping. We could not verify a Trustpilot aggregate. The prepaid structure is the key consideration: it is a full year's price paid up front. Read the HealthRx review.

Sprout: how much does it cost and what do you get?

Sprout's starting prices are $149 a month for compounded semaglutide and $199 for tirzepatide, with a brand-name Wegovy option listed from $1,799 and prescriptions shipped within 2 days. Trustpilot: 4.1 from 188 reviews. Read the Sprout review.

ro: how much does it cost and what do you get?

ro sells brand-name medication only. The Wegovy pill costs $149 the first month and then $299, Wegovy pens start at $199, and Zepbound KwikPens cost $299 the first month and then $399-$449. Each is added to the Body membership ($39 the first month, then $74-$149 a month), and the medication is billed separately so insurance can cover it where your plan allows. ro has an in-house pharmacy with home delivery, consultations with board-certified providers and ongoing dose adjustments. It is the route for anyone who wants the FDA-approved product and either has coverage or will pay cash for it. Read the ro review or see ro alternatives.

Two more providers, Wellorithm and bmiMD, are listed on our reviews index with the information we have, but we could not fully verify them in time for this guide.

Semaglutide starts at 0.25 mg a week and rises every four weeks to a 2.4 mg maintenance dose by week 17; tirzepatide starts at 2.5 mg and rises in 2.5 mg steps to a maintenance dose of 5, 10 or 15 mg. In the first 12 weeks, expect appetite to drop within days, mild nausea or constipation around each step-up, and steady loss of about one to two pounds a week once you are past the starting doses.

Both drugs begin low and climb in stages so your digestive system can adjust. The tables below follow the approved Wegovy and Zepbound labels. Compounded programs use the same approach, usually with the same milligram steps for tirzepatide and the same or smaller steps for semaglutide, since a vial lets a clinician prescribe in-between doses.

Semaglutide titration (Wegovy label)

Tirzepatide titration (Zepbound label)

Every increase is "if tolerated." Staying an extra month at one dose because of nausea is common and does not mean the drug is failing. Clinicians also stop below the top dose when a lower one is working: the labels allow 1.7 mg semaglutide, and 5 or 10 mg tirzepatide, as maintenance doses.

Weeks 1-2: what does the starting dose feel like?

Appetite usually falls within a few days, and many people find themselves skipping lunch without noticing. Mild nausea, early fullness, burping and reflux are common, particularly one to three days after the injection, and some people feel tired. Weight change at this point is mostly water and smaller meals; the scale may drop two to five pounds or not move.

Weeks 3-8: what changes with the first dose increases?

Each increase brings a few days of returning side effects that then settle. For many people constipation overtakes nausea as the main issue, and fiber, water and movement handle most cases. Food aversions may show up, usually to fatty, fried or very sweet foods, and eating them anyway is the most common trigger for bad nausea. Weight loss becomes steady, typically one to two pounds a week.

Weeks 9-12: what matters at the middle doses?

By now most people are losing at a steady pace and know which foods and portion sizes keep side effects quiet. Protein becomes the priority: with appetite suppressed it is easy to eat too little of it, and losing muscle is the price of losing weight fast without enough. Our guide to what to eat on GLP-1 medication is built around that. People also ask about injection-site reactions, hair shedding in the months after rapid loss, and "Ozempic face" (a hollow look from losing facial fat quickly). Hair shedding and facial volume loss come from fast weight loss in general rather than from the drug itself; see Ozempic and hair loss and Ozempic face.

How can you manage GLP-1 side effects?

• Eat smaller meals slowly, and stop at the first sign of fullness, which now comes sooner.
• Skip high-fat and fried food on injection day and the day after.
• Drink plenty of fluids; constipation and headaches usually trace back to dehydration.
• If nausea peaks in the hours after your dose, inject in the evening and sleep through it.
• Contact your clinician before the next dose if you are vomiting, cannot keep fluids down, or have side effects lasting more than a few days. The usual fix is to hold the dose, not to push through.

Which symptoms need urgent medical care?

• Possible pancreatitis: severe, persistent abdominal pain, with or without vomiting, that may spread to the back.
• Possible gallbladder disease: severe pain in the upper right abdomen, fever or yellowing skin.
• Thyroid warning signs from the boxed warning: a lump or swelling in the neck, trouble swallowing or persistent hoarseness.
• In people with diabetes: sudden vision changes, which need an eye exam.

These are rare, and they are the reason a licensed clinician stays involved. The semaglutide side-effects guide and first month on weight-loss medication cover them in detail.

Trial participants lost an average of about 15% of body weight on semaglutide at 68 weeks and 15% to 21% on tirzepatide at 72 weeks, with the steepest loss between months three and six. The first two months bring only a few percent because doses are deliberately low, and almost everyone hits a plateau at some point.

Knowing the shape of the trial curves before you start tells you when to be patient and when to raise questions.

Months 1-2: why is early weight loss slow?

The starting doses produce modest loss, a few percent of body weight by week eight in the trials. This is when people give up because "it isn't working." It is working; the dose is kept low on purpose.

Months 3-6: when does weight loss speed up?

This is the steepest stretch. Once the dose reaches the middle of the schedule, one to two pounds a week is typical, and the STEP 1 curve passes 10% of starting weight by six months. Our guide to how long semaglutide takes to work traces the curve month by month.

Months 6-12: does weight loss keep going?

Yes, more slowly, as the maintenance dose settles in. In STEP 1 the 68-week average of 14.9% was largely in place by about month twelve. In SURMOUNT-1, the higher-dose curves were still heading down at 72 weeks.

What should you do about a plateau?

Everyone reaches one. Work through these in order:

1. Confirm you are really at a maintenance dose and have been for at least eight weeks.
2. Look at protein, sleep and alcohol, which dampen results more than anything else.
3. If you are below the top dose, ask about an increase.
4. Only after that, consider changing molecule.

Weight-loss plateau: what to do covers each step.

Can you switch molecules or providers mid-treatment?

Yes to both. Moving from semaglutide to tirzepatide after a plateau is common and clinically routine; the clinician restarts tirzepatide at a low dose rather than converting to an equivalent one. Changing providers is easier than it sounds: the new provider does its own intake and writes a fresh prescription, and most will keep you on your current dose if you can document it. The guide to switching from Ozempic lays out the sequence, and head-to-head pages such as embody vs welludr and welludr vs embody vs TrimRx compare the terms that matter when you move.

Do you have to stay on a GLP-1 forever?

The extension data are as clear as it gets: when the drug stops, appetite comes back and most of the weight follows within a year. Clinicians manage maintenance by keeping patients on the maintenance dose long term, stepping down to the lowest dose that works, or spacing out injections, always under supervision. The evidence does not support a short course as a "reset." Budget for the long haul, which is why the year-one math and commitment terms above matter more than the first-month price.

What results are unrealistic?

A claim like "I lost 50 pounds in 3 months" is one person's experience at one dose and one starting weight. Trial averages are the only numbers that describe what a population like you went through, and they describe a year, not a season. A provider's role is to prescribe and support you safely; it cannot turn you into a faster responder, and one that hints otherwise is marketing. Our GLP-1 weight-loss statistics page gathers the trial results and the dated price index in one place.

Buy only from a provider that requires a real clinician review, names a US state-licensed pharmacy, labels the medication with that pharmacy's name, and never calls a compounded product FDA-approved. Walk away from any seller offering GLP-1s without a prescription, as "research chemicals," for crypto or gift cards, or below about $49 a month for semaglutide.

The legitimate market in this guide operates alongside an illegitimate one that uses identical language. The FDA concerns page cited earlier describes products sold without prescriptions, products containing the wrong form of the molecule, and dosing errors from unlabeled vials. These signs tell the two apart.

What are the red flags of a fake GLP-1 seller?

• No prescription required, or a "consultation" that is just a checkbox.
• No pharmacy named, or a pharmacy located outside the United States.
• A compounded product labeled FDA-approved.
• Medication sold as "research chemicals," "for research use only," or in pre-filled pens of unknown origin.
• Payment only by cryptocurrency, wire transfer or gift card.
• A price far below the verified range in this guide; under roughly $49 a month for semaglutide, no legitimate margin remains.
• No physical address, no phone number and no named company.

How can you verify a provider in five minutes?

1. Search for the pharmacy on its state board of pharmacy license lookup.
2. Check the telehealth company in LegitScript's certification lookup. embody is certified, and certification is a meaningful signal.
3. Read the 50 newest Trustpilot reviews rather than the star rating, noting what people complain about and whether the company replies.
4. Find the refund and cancellation policies on the provider's own site, not in a review.
5. Confirm the molecule is semaglutide or tirzepatide base, not "semaglutide sodium" or "semaglutide acetate," which the FDA has flagged as not the approved active ingredient.

How should GLP-1 medication be stored and handled?

Keep it refrigerated at 36-46°F (2-8°C) and never frozen. Compounded vials carry a beyond-use date, usually 28 days once opened and sometimes counted from the compounding date; the 28-day rule explainer explains why. Use a fresh needle every time, never share one, and put used sharps in a sharps container rather than the trash. Do not use a vial that looks cloudy or discolored.

Do GLP-1s interact with surgery, alcohol or mood?

Tell every clinician you see that you take a GLP-1, especially before any procedure under sedation: slower stomach emptying increases aspiration risk, and anesthesiologists often ask you to pause the drug a week beforehand. Alcohol is not off-limits, but it hits harder on a near-empty stomach and many people lose interest in it. Our guide to GLP-1 and mental health covers mood effects, which the labels ask prescribers to watch for.

Can you use an online GLP-1 provider in any state?

Only in states where the provider's clinicians hold a license, and most providers list the states they cover. If you move, let the provider know, because a clinician licensed in your new state may need to rewrite the prescription.

Insurance sometimes covers brand-name Wegovy or Zepbound for weight loss, almost never covers compounded GLP-1s, and requires a prescription either way. HSA and FSA funds can generally pay for prescribed treatment, compounded included. Medicare's GLP-1 Bridge pilot is reported to charge a flat $50 a month for the approved drugs through December 2027.

Will commercial insurance cover a GLP-1 for weight loss?

It depends entirely on your plan. Many plans cover GLP-1s for type 2 diabetes but far fewer cover them for weight management alone, and your formulary is the only definitive answer. Expect prior authorization involving BMI thresholds, documented conditions and sometimes step therapy. A telehealth prescriber can handle that process as well as an in-person doctor, and ro's model is built around it. When coverage is approved, the manufacturers' savings offers are reported to lower the monthly copay to a small fraction of list price; we cite those figures from dated sources and have not verified them. See the GLP-1 insurance guide and what to do if you lose Zepbound or Wegovy coverage for the detail.

Can you pay for a GLP-1 with an HSA or FSA?

Generally yes. A prescribed medication is normally an eligible expense, including compounded medication from a licensed pharmacy, and Medvi and SHED state HSA/FSA eligibility outright. Save the itemized receipt showing the prescription. Membership fees and coaching may not qualify, so check with your plan administrator.

Does Medicare cover GLP-1s for weight loss?

Medicare Part D has traditionally excluded weight-loss drugs. The GLP-1 Bridge pilot is reported to charge a flat $50 a month for the approved medications through December 2027. That figure comes from dated third-party sources, and our GLP-1 after 65 guide explains the eligibility conditions and what to confirm with your plan.

When is paying cash cheaper than using insurance?

With a high-deductible plan, a brand-name pen costing four figures a month can leave you paying more before the deductible is met than a full year of compounded semaglutide at $49 to $99 a month. Run both scenarios against your deductible and coinsurance before assuming insurance is the cheaper route; weight-loss medication without insurance walks through the comparison.

For the lowest cost over a year, welludr's $49 semaglutide plan; for a no-strings trial, embody at $69 month to month; for the FDA-approved product with possible insurance, ro; and if you will not inject, the Wegovy pill or Foundayo. Below, four common readers are walked through the same four decisions (molecule, route, provider, budget) using only verified terms.

"I want the lowest monthly cost, and I'm committing for a year"

• Molecule: semaglutide. The gap to tirzepatide is $40 a month at the cheapest provider and $100 or more elsewhere.
• Route: compounded.
• Provider: welludr at $49 a month on the 12-month plan, billed monthly, same price at every dose, shipped every four weeks in 3-5 business days, rated 4.6 on Trustpilot from 2,188 reviews.
• Year-one cost: $588.

Two trade-offs come with it: a longer shipping window than the fastest providers, and a twelve-month commitment. Read the cancellation terms before signing, and if you have never taken a GLP-1, consider a first month at embody to see how you tolerate it. The other committed option is HealthRx's $99 prepaid year ($1,188 at checkout, overnight shipping), which costs about twice as much in exchange for faster delivery.

"I want to try it for a month or two with no strings attached"

• Molecule: either. Without a commitment the gap is $50 a month (embody $69 vs $119).
• Route: compounded.
• Provider: embody, month to month and cancel anytime, at $69 for semaglutide or $119 for tirzepatide, with 1-2 day cold-chain shipping, LegitScript certification, clinician review usually within 24 hours, and a full refund if you are not approved.

Other no-commitment options: Eden at $99/$129 flat with 24/7 human support and a 4.5 rating from 4,917 reviews; altRx at $89/$149 on promotion with Buy Now, Pay Later; and DirectMeds at $147 flat for either molecule with 1-2 day shipping. If you are still going after month three, redo the math from the first scenario: a year at embody costs $828 compared with $588 at welludr.

"I want the FDA-approved product, and I might have insurance"

• Molecule: whichever your plan covers; many formularies cover one but not the other.
• Route: brand-name through a prescriber that bills insurance.
• Provider: ro. Its membership ($39 the first month, then $74-$149 a month) is billed separately from the medication so coverage can apply to the pen or pill, and it handles prior authorization.

If coverage is denied, cash options are ro's Zepbound from $299 the first month then $399-$449, ro's Wegovy pill from $149 then $299, or altRx's flat $1,249 Zepbound if you also want access to compounded options. Check the manufacturers' savings offers through your plan before paying cash; the insurance guide lists the questions to ask.

"I won't inject"

Two approved pills are available: the Wegovy pill (oral semaglutide 25 mg, approved December 2025) and Foundayo (orforglipron, approved April 1, 2026). Both are brand-name and priced that way. ro sells the Wegovy pill at $149 the first month and then $299, plus membership. Foundayo lists $149 to $349 a month self-pay by dose through LillyDirect, a manufacturer figure we have not verified. The compounded "pills," "drops" and "troches" some programs sell are not these products.

If the needle is the only obstacle, it helps to know that it is short and thin, the injection is weekly, and most people who were nervous call the first one a non-event, as the first-month guide describes. For this reader, the Foundayo vs Wegovy pill comparison is the place to start.

What if your priorities fall somewhere in between?

• Coaching and a dietitian bundled in: Medvi at $99 on promotion, all-inclusive, HSA/FSA accepted, 4.3 from 14,987 reviews.
• A results guarantee: SHED at $199, with money back if you have not lost 5% in 120 days.
• Unlimited clinician contact and custom dosing: TrimRx at $149 with the discount applied.
• Fast tirzepatide with no plan: DirectMeds at $147 flat with 1-2 day shipping.

The matching quiz weighs these trade-offs for you in under a minute.

The labels apply to all adults regardless of sex or age, but some situations change the practical advice: pregnancy timing and contraception for women, muscle and bone protection around menopause and after 40, medication and kidney checks after 65, and protein plus strength training for athletes. People with type 2 diabetes face different brands and better coverage odds.

What should women know before starting a GLP-1?

About three-quarters of STEP 1 participants were women, so the headline results describe women more closely than men. Two label points stand out: stop both drugs at least two months before a planned pregnancy, and on tirzepatide use a backup birth-control method for four weeks after starting and after each dose increase, because it can make oral contraceptives less effective. PCOS often drives weight gain that responds to GLP-1s, and some clinicians prescribe for it specifically, so raise it at intake. Our guide to GLP-1 weight loss for women covers cycle effects, fertility timing and body composition.

Do GLP-1s help with menopause weight gain?

Weight gain around menopause has a hormonal cause that diet alone handles poorly, and GLP-1s are increasingly prescribed alongside or instead of hormone therapy. The trade-off is muscle and bone: losing weight quickly in years when both are already declining makes protein intake and resistance training more important. Menopause weight gain explains the physiology.

Is a GLP-1 different after 40?

Metabolism slows and lean mass is harder to hold on to, which points to the same two priorities (protein and strength training) and to patience with titration instead of racing to the top dose. High blood pressure, cholesterol or blood sugar are also more likely to be the weight-related condition that qualifies someone with a BMI between 27 and 29. See GLP-1 weight loss over 40.

Can you take a GLP-1 after 65?

Yes. The labels set no upper age limit, and older adults were part of the trials. The practical concerns are polypharmacy (more medications whose absorption could be affected), kidney function, the chance that appetite suppression slides into under-nutrition, and Medicare rules, which historically kept weight-loss drugs out of Part D and shifted in 2026 with the GLP-1 Bridge pilot described above. GLP-1 after 65 addresses all four.

How can athletes and lifters protect muscle on a GLP-1?

Lean mass is the concern. Any large weight loss includes some muscle, and research on GLP-1s suggests the share is similar to diet-driven loss, so the same tools manage it:

• A protein target of roughly 1.2 to 1.6 grams per kilogram of goal body weight.
• Progressive resistance training three times a week.
• A slower titration if performance starts to drop.

Low appetite makes a protein target genuinely hard to hit, so it has to be planned, not left to chance. Exercise while on GLP-1 medication includes a program.

What changes if you have type 2 diabetes?

Ozempic and Mounjaro are the diabetes-indicated brands, and insurers cover that indication far more often. If you have diabetes, discuss with your prescriber which indication to pursue, because it affects the brand, the coverage and the monitoring. Insulin and sulfonylureas raise the risk of low blood sugar when combined with a GLP-1. Mounjaro vs Ozempic and Ozempic vs Wegovy sort out the names.

Do GLP-1s help with emotional eating?

Many people say the medication quiets "food noise," the steady background urge to eat that has nothing to do with hunger, and it is one of the most consistent things reviewers mention. That is not the same as addressing why emotional eating happens, and the months on medication are a good time to work on it, because the drug turns the volume down enough to think clearly. Emotional eating and weight loss is written for exactly that period.

Get the best GLP-1 results by eating protein first at every meal (25 to 40 grams), getting enough fiber and fluids, strength training two or three times a week, and protecting sleep. Avoid the common mistakes in one-star reviews: prepaying too early, comparing promo prices, doubling missed doses and stopping abruptly at goal weight.

The drug handles the hardest part, appetite, but trial participants also received lifestyle counseling, and reviewers who report disappointing results tend to describe the same few avoidable errors. Here is the condensed version.

How much protein should you eat on a GLP-1?

Aim for 25 to 40 grams per meal and put protein on the plate first. With appetite suppressed it is easy to drift down to 900 calories a day of whatever is handy, and muscle pays the price. Good options include Greek yogurt, eggs, fish, poultry, tofu, legumes, and protein shakes when whole food feels like too much. What to eat on GLP-1 medication has meal patterns that also keep side effects calm.

How do you prevent constipation on a GLP-1?

Constipation is the complaint that lingers longest after the first weeks. Twenty-five grams of fiber a day from vegetables, fruit, oats and legumes, two to three liters of water and a daily walk fix most cases. A stool softener is the next step, and your clinician the one after.

Is strength training or cardio better on a GLP-1?

Strength training. Cardio benefits your health, but resistance work is what keeps the muscle that weight loss would otherwise strip away. Two or three sessions a week of compound movements (squats, hinges, pushes and pulls) at any level is the single most important recommendation. Exercise on GLP-1 medication has beginner and intermediate programs.

Do sleep and alcohol affect GLP-1 results?

Yes. Short sleep raises hunger hormones enough to blunt the drug's effect, and alcohol adds empty calories that also hit harder on a nearly empty stomach. Neither has to be perfect, but both are the first things to check when a plateau shows up early.

What are the seven most common GLP-1 mistakes?

1. Prepaying for a year before you know you tolerate the drug. The $49 plan suits month four, not necessarily month one. A first month at a no-commitment provider is inexpensive protection.
2. Comparing first-month prices. altRx's $89 and Medvi's $99 are promotions against $199, and SHED's discount applies to month one only. Compare regular rates.
3. Ignoring the published shipping window. A 5-7 day window is the stated term, not a delay. Expecting embody's 1-2 days from a provider that promises 3-5 business days is the most common avoidable complaint we see.
4. Taking a double dose after missing one. The Wegovy label says to take a missed dose within 5 days and otherwise skip it; the Zepbound label says within 4 days. Never take two doses to catch up.
5. Forcing through severe nausea to stay on schedule. Holding a dose for a month is routine and costs nothing, while a week of vomiting costs you the month anyway.
6. Ignoring the beyond-use date on a compounded vial. It is usually 28 days once opened. Medication past that date is not necessarily dangerous, but its potency is no longer reliable.
7. Stopping abruptly at goal weight. Extension data show most of the weight returns within a year. Have the maintenance conversation before you reach your goal, not after.

What is the difference between Ozempic, Wegovy, Mounjaro and Zepbound?

• Ozempic and Wegovy are both semaglutide at different doses with different approvals: Ozempic for type 2 diabetes, Wegovy for weight management.
• Mounjaro and Zepbound are both tirzepatide, split the same way.
• "Compounded Ozempic" is not a real product; the term means compounded semaglutide.
• Rybelsus is an older oral semaglutide for diabetes; the Wegovy pill is the oral version for weight management.
• Foundayo is a different molecule (orforglipron) from a different company.

Zepbound vs Wegovy vs Ozempic explains all three side by side.

GLP-1 glossary

• 503A pharmacy: a state-licensed pharmacy that compounds for an individual patient on a prescription; the usual source for telehealth GLP-1s.
• 503B outsourcing facility: an FDA-registered facility allowed to compound larger batches under federal oversight.
• Beyond-use date (BUD): the date after which a compounded preparation should not be used; often 28 days from first use for vials.
• Titration: the schedule for raising the dose over months to limit side effects.
• Maintenance dose: the dose you stay on after titration ends; trial results are measured at this dose.
• Units: the marks on an insulin-style syringe used to draw a compounded dose from a vial. Your prescription converts milligrams into units for your vial's concentration, and the provider should confirm that conversion in writing.
• Prior authorization (PA): an insurer's approval step for a brand-name GLP-1, usually requiring BMI and comorbidity documentation.
• LegitScript: independent certification for online pharmacies and telehealth companies that checks licensing and practices; embody holds it.
• Treatment-regimen vs efficacy estimand: two ways trials report outcomes. The first covers everyone randomized; the second covers only those who stayed on treatment, always produces the bigger number, and is the one marketing tends to quote.

Check five things when a compounded GLP-1 arrives: a complete pharmacy label, the concentration and your written units-to-milligrams conversion, the molecule (semaglutide or tirzepatide base, not a salt form), any added ingredients, and the beyond-use date. The units conversion is where most of the dosing errors reported to the FDA happen.

Brand-name pens hide the pharmacology inside a click-and-inject device. Compounded medication usually comes as a small glass vial with a bag of insulin syringes, and the one skill it requires is reading what you received.

What should a compounded GLP-1 label show?

A properly compounded prescription label lists your name, the prescriber's name, the pharmacy's name and address, the drug and its concentration (for example, "semaglutide 2.5 mg/mL"), the total volume, the directions, the compounding date and a beyond-use date. A vial without a pharmacy name, or marked "for research use only," did not come through the route this guide describes, whatever the website claimed.

How do you convert milligrams to units on the syringe?

Compounded semaglutide is dispensed in a range of concentrations, so your weekly dose in milligrams must be translated into units on an insulin syringe for your vial's specific concentration. The provider should give you that conversion in writing (for example, "draw 10 units for 0.25 mg"), and it changes whenever the concentration changes, which can happen between refills. This is where the FDA's reported dosing errors occur: patients using old instructions with a new vial, or mixing up milligrams and milliliters. If the number on the syringe and the number in your instructions do not match, do not inject until the provider confirms.

How do you know the vial contains the right molecule?

The approved drugs contain semaglutide or tirzepatide base. The FDA has flagged compounded products made with salt forms (semaglutide sodium and semaglutide acetate) as a different active ingredient that is not eligible for compounding under the law. The label should read "semaglutide," not a salt name. If the provider's pharmacy will not tell you which form it uses, treat that as your answer.

Do added ingredients like B12 or NAD+ help?

Some compounded formulations include vitamin B12, NAD+ or other additives. No trial evidence shows any of them improve weight loss; the usual stated reasons are to ease nausea or to create a documented clinical difference from the approved product. They are not harmful at the doses used, but they are not why the medication works, and a program that leans on them in its marketing is selling the garnish. welludr offers a GLP-1 plus NAD+/B12 microdose among its options; it is optional, not required.

How long does a compounded vial last, and how should it be stored?

A compounded vial usually carries a beyond-use date of 28 days from the first puncture, and the pharmacy's stability data may allow longer before it is opened. Store it in the fridge but not in the door, where the temperature swings, and let it sit at room temperature for a few minutes before injecting to reduce stinging. If it arrives warm because a cold pack failed in transit, take a photo and contact the provider before using it; legitimate providers replace it.

Should you choose a vial or a pen?

Brand-name products come in pre-filled, pre-dosed pens, and some compounded programs offer pens too, at higher prices. Vials cost less and let a clinician prescribe any dose, which is the legal basis for compounding. Pens are simpler and skip the conversion step. If drawing a dose makes you anxious, ask the provider whether a pen is available and what it costs, or request a first-dose video call, which several providers offer.

In the first 90 days: confirm eligibility and pick a no-commitment provider, check the vial label and units on delivery, log every weekly dose, eat protein first, start strength training by week 5, and at week 12 decide whether to stay, commit to a plan or switch. Here is the whole guide as a checklist in the order you will use it.

Before you apply

• Work out your BMI and note any weight-related condition. The thresholds are 30, or 27 with a condition.
• Run through the disqualifiers: thyroid cancer history, MEN 2, pancreatitis, severe GI disease, pregnancy plans.
• Write down every medication and supplement you take, with doses.
• Pick the molecule: semaglutide first unless you have a specific reason for tirzepatide.
• Pick the commitment: month to month to begin with if this is your first GLP-1.
• Choose a provider using the twelve checks, and read its refund-if-declined and cancellation terms on its own site.
• Find the regular price behind any promotion and write down what month four will cost.

Week 1

• Fill in the intake truthfully, with your ID and any recent labs on hand.
• Reply to clinician questions the same day.
• When the package arrives: refrigerate it, check the label (your name, pharmacy name, drug, concentration, beyond-use date) and get the units-to-milligrams instruction confirmed in writing.
• Take the first injection on a day when you can rest and eat lightly, and log the date, dose and how you felt.

Weeks 2-4

• Inject on the same day each week, rotate sites and log every dose.
• Put protein first at every meal, drink two to three liters of water and walk daily.
• Expect mild nausea and early fullness, and skip fried and very sweet food on injection day.
• Message the clinician before the next dose if side effects go beyond mild.
• Set a refill reminder and confirm the next shipment date in the portal.

Weeks 5-8

• Take the first dose increase if you are tolerating the current one, and expect two or three days of side effects to return.
• Begin or keep up resistance training, two to three sessions a week.
• Watch for constipation and reach for fiber and fluids first.
• Compare your month-two charge with the figure you wrote down before applying.

Weeks 9-12

• Take the second increase if tolerated; weight loss should be steady by now.
• Be honest about protein intake, since low appetite makes under-eating it the default.
• If you committed or prepaid, decide now whether the medication suits you well enough to continue. If you started month to month and plan to stay, re-run the year-one math and consider a committed plan.
• Schedule the maintenance conversation with your clinician now, well before you get close to your goal.

After three months you will know three things no guide can predict: how well you tolerate the drug, how strongly you respond to it, and whether your provider is the one you want for the full year. Those answers, more than any ranking, should drive what comes next.

Between December 2024 and spring 2025 the FDA ended the GLP-1 shortage era that allowed mass compounding; the Wegovy pill (December 2025) and Foundayo (April 2026) brought approved oral options; compounded prices settled at a $49 floor; and Medicare's GLP-1 Bridge pilot opened a reported $50-a-month route. This market changes faster than most of medicine, and a guide from 2024 would already be wrong in four places.

How did the end of the shortage change compounding?

The FDA's December 2024 and February 2025 rulings that tirzepatide and semaglutide were no longer in shortage, followed by the end of the enforcement grace periods in spring 2025, closed the window in which compounding pharmacies could copy the approved drugs at scale. The programs still operating survived by going back to patient-specific compounding with a documented clinical reason, by naming their pharmacies and, in several cases, by adding brand-name options. Expect the FDA to keep scrutinizing marketing language, as its June 2026 warning letter over "FDA-approved" claims showed, and expect legitimate providers to keep tightening how they describe what they sell.

What did the arrival of GLP-1 pills change?

The Wegovy pill (December 2025) and Foundayo (April 2026) turned "I won't inject" from a dead end into a budgeting question. Both are brand-name and priced in roughly the $149-$349 range by dose through the manufacturers and telehealth, which is three to seven times the cheapest compounded injection and a fraction of a brand-name pen. The likely next development is price pressure on compounded products from below and on brand-name pens from above; our price-change log is where that will appear first.

Are compounded GLP-1 prices still falling?

They have settled. The verified compounded floor is $49 a month for semaglutide on a committed plan and $69 month to month, and $89 and $119 for tirzepatide. Those numbers have held steady across the period we have logged. The movement has come from promotions, which start and expire, and from the commitment terms behind the headline rates. Watch for low headline prices tied to longer plans; that is where future "cheapest" claims will come from, and this guide's year-one math is how to read them.

What changed in Medicare coverage?

The GLP-1 Bridge pilot, reported at a flat $50 a month for the approved medications through December 2027, is the first substantial Medicare route to these drugs for weight management. We cite that figure from dated third-party sources and have not verified it. The eligibility conditions are what to confirm with your plan, and our GLP-1 guide for over-65s tracks them.

Why do provider names keep changing?

Company names, parent companies and pharmacy partners turn over constantly; welludr, for example, became welludr in October 2026 without altering its plans or prices, and more rebrands will follow. What stays fixed is the standard: semaglutide or tirzepatide from a named, licensed pharmacy, on a prescription written for you, at a price with its conditions spelled out. Measure every provider, and every future update of this guide, against that.

How is this guide kept up to date?

We re-verify prices on a schedule and whenever we catch a change, and the "verified" date on the price table marks the most recent check. Clinical and regulatory content is revised when labels or FDA guidance change, and the update date at the top moves only when something on the page has actually changed. If a figure here no longer matches a provider's site, use the contact details on our about page to reach the team that maintains it.

Can I get Ozempic online for weight loss? Ozempic is approved for type 2 diabetes, not weight loss; the approved semaglutide brand for weight loss is Wegovy, which telehealth providers such as ro prescribe. Most people searching for "Ozempic for weight loss" end up on compounded semaglutide at $49 to $199 a month or on Wegovy at brand-name prices. How to get Ozempic online covers each option.

Can I get a GLP-1 without seeing a doctor? No. Every legal route requires a licensed clinician to review your history and write a prescription. That review can happen entirely online and without a live appointment, which is what "no clinic visit" means. Can you get Ozempic without a doctor explains the law.

What is the cheapest GLP-1 online? As verified on October 16, 2026, the cheapest compounded semaglutide is $49 a month on welludr's 12-month plan, or $69 a month with no commitment at embody. The cheapest compounded tirzepatide is $89 at welludr on the plan and $119 month to month at embody. Our cheapest GLP-1 page updates with every price change.

Is compounded semaglutide safe? Compounded semaglutide contains the same active ingredient, prepared by a state-licensed pharmacy on a prescription. It is not FDA-approved, has no trials of its own, and its quality depends on the pharmacy, and the FDA has documented adverse events, dosing errors and wrong-ingredient products in the wider market. Your protection is a named, licensed pharmacy, a prescription written for you and a properly labeled product.

Does the price go up as my dose increases? Not at any provider in this guide; each publishes one price per medication across all doses. Your price changes only when a promotion ends (altRx, Medvi, SHED) or, at welludr and HealthRx, depending on whether you are on the 12-month plan.

How much weight will I lose on a GLP-1? Trial averages were about 15% of body weight on semaglutide at 68 weeks and 15% to 21% on tirzepatide at 72 weeks, depending on dose. Individual results vary widely. Most of the loss happens between months three and nine.

How fast will my GLP-1 medication arrive? Published delivery windows: 1-2 days at embody and DirectMeds, often next day at TrimRx, overnight at HealthRx, within 2 days at Sprout, 3-5 business days at welludr and 5-7 days at altRx. Allow one to three extra days for the clinician review before anything ships.

Do I need insurance to get a GLP-1 online? No. The compounded prices in this guide are cash prices, and embody, altRx and DirectMeds state that no insurance is needed. Insurance rarely covers compounded medication but sometimes covers brand-name.

Can I use my HSA or FSA for a GLP-1? Generally yes, for a prescribed medication. Medvi and SHED state eligibility explicitly. Keep the itemized receipt.

What happens if I stop taking a GLP-1? Appetite comes back. In the semaglutide extension study, participants regained about two-thirds of the weight they had lost within a year, so plan for maintenance from the beginning.

Which is better, semaglutide or tirzepatide? Tirzepatide produced more weight loss in its trials. Semaglutide costs $40 to $110 a month less at the same provider, has a longer track record and comes in pill form. For a first course, most people start on semaglutide and switch only if they plateau.

Can I switch GLP-1 providers mid-treatment? Yes. The new provider runs its own intake and writes a new prescription, and most will continue your current dose if you can document it. Check the cancellation terms at the provider you are leaving, especially if you are on a 12-month plan.

Are compounded GLP-1 "pills" and "drops" the same as the Wegovy pill? No. The Wegovy pill and Foundayo are FDA-approved formulations backed by their own trials. Compounded tablets, drops and troches are compounded preparations that have not been studied.

Do any online GLP-1 providers offer a money-back guarantee? embody gives a full refund if a clinician does not approve you. SHED refunds your money if you have not lost 5% of body weight in 120 days. Every other provider's cancellation terms govern refunds, and our review pages quote them.

Can I buy semaglutide from overseas or without a prescription? Not legally and not safely. Products sold without a prescription or shipped from unlicensed sources are where the FDA has found counterfeits, wrong ingredients and unlabeled vials. Verified prices in this guide start at $49 a month, and no legitimate product is meaningfully cheaper.

Can I take a GLP-1 with metformin or other weight-loss medication? Often, with supervision; metformin is commonly prescribed alongside. Insulin and sulfonylureas need dose adjustments because of the risk of low blood sugar, and two GLP-1 products should never be combined. Declare every medication at intake.

What if I move to another state while on a GLP-1? Tell the provider. Prescribing requires a clinician licensed in your state, so the prescription may need to be rewritten, and most providers list the states they serve.

How do I travel with GLP-1 medication? Keep vials or pens cold with a small cold pack. Most labels allow some time at room temperature (the Wegovy pen, for example, up to 28 days below 86°F), and your pharmacy's instructions apply to a compounded vial. Carry the labeled prescription through airport security.

What is the difference between a GLP-1 vial and a pen? A pen is pre-filled and pre-dosed: you dial and inject. A vial requires drawing the dose into a syringe using a units conversion from your provider. Most compounded programs ship vials, which is part of why compounded costs less, while brand-name products use pens.

How can I tell if a telehealth GLP-1 provider is legitimate? A legitimate provider names its pharmacy and its clinicians' licensing, requires a genuine intake, labels the medication with the pharmacy's name, lists a physical address and phone number, has years of Trustpilot history, and never calls a compounded product FDA-approved. LegitScript certification, which embody holds, independently checks the same things.

Every provider price, shipping window, plan condition, refund term and Trustpilot figure in this guide comes from our verified price index, read directly from each provider's site on a dated schedule (most recently October 16, 2026) and logged whenever it changes. Figures from manufacturers, government programs or third-party trackers are dated, linked and marked as not verified by us.

Clinical statements come from the FDA-approved labels and the peer-reviewed trial reports linked throughout, and the medical and scientific content has been checked for accuracy by our named medical reviewer under the process on our medical review policy page. We earn commissions from some providers we link to. That affects neither the prices shown nor the facts stated, and our how we rank page explains exactly how the ranking is built.

This guide is for information only and is not medical advice. Whether a GLP-1 medication is right for you is a decision for you and a licensed clinician who knows your history. Compounded medications are not FDA-approved.

Where should you go from here?

• Ready to pick a provider: the provider ranking or the matching quiz.
• Price is the deciding factor: cheapest GLP-1 online and what you will really pay.
• Still choosing the molecule: tirzepatide vs semaglutide and best tirzepatide online.
• Want the brand-name product: the Zepbound and Wegovy pill price guides and the ro review.
• Deciding between two providers: the head-to-head pages, beginning with embody vs welludr.
• Already started and wondering what is normal: the first month and side effects guides.